Geode Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $344M | Sell |
|
|||||
2025
Q1 | $377M | Buy |
|
|||||
2024
Q4 | $401M | Buy |
|
|||||
2024
Q3 | $391M | Buy |
|
|||||
2024
Q2 | $334M | Buy |
|
|||||
2024
Q1 | $190M | Buy |
|
|||||
2023
Q4 | $171M | Sell |
|
|||||
2023
Q3 | $187M | Buy |
|
|||||
2023
Q2 | $178M | Buy |
|
|||||
2023
Q1 | $170M | Buy |
|
|||||
2022
Q4 | $184M | Buy |
|
|||||
2022
Q3 | $132M | Sell |
|
|||||
2022
Q2 | $150M | Sell |
|
|||||
2022
Q1 | $115M | Sell |
|
|||||
2021
Q4 | $164M | Buy |
|
|||||
2021
Q3 | $129M | Sell |
|
|||||
2021
Q2 | $127M | Buy |
|
|||||
2021
Q1 | $111M | Buy |
|
|||||
2020
Q4 | $100M | Buy |
|
|||||
2020
Q3 | $60.9M | Sell |
|
|||||
2020
Q2 | $75M | Buy |
|
|||||
2020
Q1 | $55.2M | Buy |
|
|||||
2019
Q4 | $47.5M | Buy |
|
|||||
2019
Q3 | $41M | Sell |
|
|||||
2019
Q2 | $40.4M | Sell |
|
|||||
2019
Q1 | $67.3M | Sell |
|
|||||
2018
Q4 | $64.8M | Buy |
|
|||||
2018
Q3 | $74.7M | Sell |
|
|||||
2018
Q2 | $66.4M | Sell |
|
|||||
2018
Q1 | $69M | Sell |
|
|||||
2017
Q4 | $101M | Sell |
|
|||||
2017
Q3 | $87.6M | Buy |
|
|||||
2017
Q2 | $90.8M | Buy |
|
|||||
2017
Q1 | $89.3M | Buy |
|
|||||
2016
Q4 | $85M | Buy |
|
|||||
2016
Q3 | $65.7M | Buy |
|
|||||
2016
Q2 | $55.8M | Buy |
|
|||||
2016
Q1 | $50.8K | Buy |
|
|||||
2015
Q4 | $58.9M | Buy |
|
|||||
2015
Q3 | $42.5M | Sell |
|
|||||
2015
Q2 | $61.5M | Buy |
|
|||||
2015
Q1 | $60.1M | Buy |
|
|||||
2014
Q4 | $42.5M | Buy |
|
|||||
2014
Q3 | $40.7M | Buy |
|
|||||
2014
Q2 | $26.5M | Buy |
|
|||||
2014
Q1 | $26.4M | Buy |
|
|||||
2013
Q4 | $31.5M | Buy |
|
|||||
2013
Q3 | $21.3M | Buy |
|
|||||
2013
Q2 | $17.4M | Buy |
|